MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Relationship between cholinergic basal forebrain volume and short-latency sensory afferent inhibition in Parkinson’s disease with varying degrees of cognitive performance

JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, AM. Castellano-Gerrero, MA. Labrador-Espinosa, B. Villarreal, L. Muñoz-Delgado, D. Macías-García, P. álvarez Toledo, M. San Eufrasio, M. Reina Castillo, S. Jesús, A. Adarmes-Gómez, F. Carrillo, MJ. Grothe, P. Mir (Sevilla, Spain)

Meeting: 2022 International Congress

Abstract Number: 1233

Keywords: Acetylcholine, Cognitive dysfunction, Neurophysiology

Category: Parkinson's Disease: Cognitive functions

Objective: To assess the relationship between volumetric measures of cholinergic basal forebrain (CBF) degeneration and short-latency sensory afferent inhibition (SAI) in Parkinson’s disease (PD).

Background: Both CBF degeneration and altered SAI, which is believed to be mediated by cholinergic projections, have been independently associated with cognitive impairment in PD [1,2]. However, the relationship between both measures has not yet been tested in the context of PD.

Method: Fifty-seven PD patients, recruited prospectively from our movement disorders unit, underwent median nerve SAI and 3T structural MRI to determine the basal forebrain volume following published procedures [3,4]. In our primary analyses, we used the total anatomic CBF space as an overall measure of CBF degeneration, and in secondary analyses we considered functionally defined anterior-medial (aCBF) and posterior-lateral (pCBF) subdivisions separately. The Parkinson’s Disease Cognitive Rating Scale (PDCRS) [4] total score (PDCRST) and the fronto-subcortical (PDCRSF-SC) and posterior cortical (PDCRSP-C) subscores were used to assess the cognitive status of the participants. Partial correlations, controlling for age, sex, years of education, and total intracranial volume, were used for statistical analyses.

Results: The percentage of SAI showed significant positive correlations with the PDCRST score (Pearson’s r = 0.33, p = 0.016) and the PDCRSP-C subscore (r = 0.54, p < 0.001), but not with PDCRSF-SC (r = 0.24, p = 0.078). The total CBF volume showed significant positive correlations with all three PDRCS scores (all p < 0.05), which were most pronounced with the PDCRSP-C score. Furthermore, we found a trend-level relationship between SAI and total CBF volume (r = 0.25, p = 0.073), which was driven by the pCBF (r = 0.32, p = 0.019; aCBF, r =0.14, p = 0.30).

Conclusion: Our results confirm that both CBF volume and the degree of cortical inhibition measured by SAI are associated with cognitive performance in PD, which reinforces the hypothesis of the role of cholinergic neurotransmission in the cognitive status of these patients. Furthermore, our results suggest that SAI represents a neurophysiological correlate of CBF degeneration in PD.

References: [1] Ray NJ et al. Brain 2018, 141: 165-75
[2] Martin-Rodriguez JF & Mir, P. Neuroscience Letters 2020, 719: 133679
[3] Tokimura H et al. Journal of Physiology 2000, 523: 503-13
[4] Fritz HJ et al. Human Brain Mapping 2019, 40: 868-78

To cite this abstract in AMA style:

JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, AM. Castellano-Gerrero, MA. Labrador-Espinosa, B. Villarreal, L. Muñoz-Delgado, D. Macías-García, P. álvarez Toledo, M. San Eufrasio, M. Reina Castillo, S. Jesús, A. Adarmes-Gómez, F. Carrillo, MJ. Grothe, P. Mir. Relationship between cholinergic basal forebrain volume and short-latency sensory afferent inhibition in Parkinson’s disease with varying degrees of cognitive performance [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/relationship-between-cholinergic-basal-forebrain-volume-and-short-latency-sensory-afferent-inhibition-in-parkinsons-disease-with-varying-degrees-of-cognitive-performance/. Accessed September 25, 2023.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/relationship-between-cholinergic-basal-forebrain-volume-and-short-latency-sensory-afferent-inhibition-in-parkinsons-disease-with-varying-degrees-of-cognitive-performance/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #23107 (not found)
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • #23972 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • #22892 (not found)
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley